Getein Biotech Inc (603387) — Net Asset Quality Index
Getein Biotech Inc (603387) has a Net Asset Quality Index of 79.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.70 Billion minus total liabilities of CN¥765.68 Million yields net assets of CN¥2.93 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Getein Biotech Inc (603387) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Getein Biotech Inc Net Asset Quality Index Over Time (2012–2025)
This chart shows how Getein Biotech Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 79.3%, representing net assets of CN¥2.93 Billion against total assets of CN¥3.70 Billion CNY. For live market cap and overall valuation, see 603387 market cap overview.
Annual Net Asset Quality Index for Getein Biotech Inc (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Getein Biotech Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Getein Biotech Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.1% | CN¥2.86 Billion | CN¥3.76 Billion | CN¥896.55 Million | ▲ +2.7 pp |
| 2024 | 73.4% | CN¥2.72 Billion | CN¥3.71 Billion | CN¥986.42 Million | ▲ +0.7 pp |
| 2023 | 72.7% | CN¥2.74 Billion | CN¥3.77 Billion | CN¥1.03 Billion | ▲ +0.2 pp |
| 2022 | 72.5% | CN¥2.66 Billion | CN¥3.68 Billion | CN¥1.01 Billion | ▼ 0.0 pp |
| 2021 | 72.5% | CN¥2.27 Billion | CN¥3.14 Billion | CN¥863.90 Million | ▼ -1.8 pp |
| 2020 | 74.2% | CN¥2.00 Billion | CN¥2.70 Billion | CN¥695.95 Million | ▼ -9.5 pp |
| 2019 | 83.8% | CN¥1.68 Billion | CN¥2.01 Billion | CN¥325.98 Million | ▼ -4.3 pp |
| 2018 | 88.1% | CN¥1.38 Billion | CN¥1.57 Billion | CN¥187.23 Million | ▼ -2.5 pp |
| 2017 | 90.6% | CN¥1.15 Billion | CN¥1.27 Billion | CN¥118.87 Million | ▲ +11.6 pp |
| 2016 | 79.0% | CN¥342.96 Million | CN¥434.09 Million | CN¥91.13 Million | ▼ -2.9 pp |
| 2015 | 81.9% | CN¥268.60 Million | CN¥328.08 Million | CN¥59.48 Million | ▲ +1.9 pp |
| 2014 | 80.0% | CN¥165.19 Million | CN¥206.45 Million | CN¥41.26 Million | ▲ +25.6 pp |
| 2013 | 54.4% | CN¥84.06 Million | CN¥154.49 Million | CN¥70.42 Million | ▲ +9.2 pp |
| 2012 | 45.3% | CN¥40.63 Million | CN¥89.78 Million | CN¥49.15 Million | — |